Biotricity, Inc. BTCY
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.69M | -2.40M | -4.02M | -4.53M | -5.40M |
| Total Depreciation and Amortization | 598.10K | 582.70K | 567.80K | 553.50K | 526.40K |
| Total Amortization of Deferred Charges | 788.90K | 745.90K | 705.30K | 810.90K | 948.70K |
| Total Other Non-Cash Items | 550.00K | 122.70K | 1.94M | 1.82M | 1.85M |
| Change in Net Operating Assets | 916.10K | 233.90K | -293.80K | 896.60K | 819.40K |
| Cash from Operations | 161.60K | -719.00K | -1.10M | -446.70K | -1.26M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 940.20K | 1.38M | 2.04M | 1.95M | 2.28M |
| Total Debt Repaid | -784.90K | -600.00K | -1.00M | -1.21M | -1.18M |
| Issuance of Common Stock | -- | -- | 0.00 | 0.00 | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | 0.00 | 0.00 |
| Issuance of Preferred Stock | -- | -- | 0.00 | 0.00 | 420.00K |
| Repurchase of Preferred Stock | -200.00K | -200.00K | -200.00K | -200.00K | -- |
| Total Dividends Paid | -24.10K | -24.00K | -24.10K | -24.00K | -23.90K |
| Other Financing Activities | -- | -- | 0.00 | 0.00 | 0.00 |
| Cash from Financing | -68.80K | 557.80K | 814.30K | 518.00K | 1.50M |
| Foreign Exchange rate Adjustments | -17.50K | -54.10K | 185.20K | 63.90K | 53.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -153.80K | 0.00 | 0.00 |
| Net Change in Cash | 75.20K | -215.40K | -253.30K | 135.10K | 290.40K |